who discovered glp-1 In an interview with El Médico Interactivo, a Medscape Network platform, Rockefeller researcher Svetlana Mojsov reflects on how her discovery of GLP- 1 has helped millions of people manage their diabetes and obesity The transformative breakthroughs in GLP-1

Description

After systemic administration, they engage both GLP1R and GIPR simultaneously in native tissue, enabling the study of receptor engagement, metabolic responses, and therapeutic effects at the cellular and organ level, going beyond localization to provide functional readouts directly in living models

who discovered glp-1 In an interview with El Mdico Interactivo, a Medscape Network platform, Rockefeller researcher Svetlana Mojsov reflects on how her discovery of GLP- 1 has helped millions of people manage their diabetes and obesity The transformative breakthroughs in GLP-1

This rapid degradation of GLP-1 has motivated the development of long-acting GLP-1R agonists, which are protected from DPP-IV degradation and can be used clinically (Kalra et al., 2021)

This hormone plays a key role in regulating appetite and digestion

Patients use Liraglutide Injection, a Glucagon-Like Peptide-1 (GLP-1) medication, along with diet and exercise to enhance glycemic control in adults and children aged 10 and up with type 2 diabetes